Have your own idea? Try our Stock Screener
UPDATED Jan 20, 2025
Discover Swedish Growth Stocks that are on the OMX. Sorted by forecasted growth, these stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ALM | SEK 146.00 | 0% | -47.9% | SEK 2.5b | SEK 193.00 | PS1x | E103.0% | n/a | Real Estate Management and Development | ||
BACTI B | SEK 35.00 | -0.8% | -51.4% | SEK 1.2b | SEK 55.00 | PS5.2x | E102.8% | n/a | Healthcare | ||
KINV B | SEK 79.23 | 4.5% | -23.0% | SEK 22.4b | SEK 101.86 | PB0.6x | E102.2% | 0% | Diversified Financials | ||
CLAV | SEK 2.09 | -0.9% | 88.3% | SEK 559.3m | n/a | PS3.1x | E102.0% | n/a | Software | ||
CAT B | SEK 26.85 | -0.6% | -12.0% | SEK 2.4b | SEK 45.00 | PS1.6x | E102.0% | 3.4% | Diversified Financials | ||
HELIO | SEK 0.41 | 17.5% | -12.4% | SEK 50.0m | SEK 1.20 | PS1.4x | E100.9% | n/a | Capital Goods | ||
NYF | SEK 103.00 | 7.1% | 22.8% | SEK 21.4b | SEK 130.00 | PS5.6x | E100.7% | 0% | Real Estate Management and Development | ||
KONT | SEK 2.52 | -3.1% | 0.8% | SEK 80.8m | SEK 5.40 | PE81.4x | E99.6% | n/a | Healthcare | ||
SYNACT | SEK 10.65 | -2.5% | 57.8% | SEK 519.5m | SEK 16.00 | PB3.1x | E99.2% | n/a | Pharmaceuticals & Biotech | ||
BONAV B | SEK 8.30 | 3.6% | -25.3% | SEK 2.7b | SEK 14.67 | PB0.4x | E99.1% | 0% | Consumer Durables | ||
DUST | SEK 3.56 | -0.6% | -67.5% | SEK 1.6b | SEK 5.65 | PB0.2x | E98.9% | 0% | Tech | ||
CTEK | SEK 13.30 | -6.2% | -30.6% | SEK 930.7m | SEK 23.33 | PE193.9x | E98.8% | n/a | Capital Goods | ||
SINCH | SEK 21.12 | 12.9% | -28.5% | SEK 17.8b | SEK 30.78 | PB0.6x | E98.3% | n/a | Software | ||
RROS | SEK 9.23 | 2.0% | -27.8% | SEK 1.4b | SEK 12.83 | PB0.8x | E97.8% | 5.4% | Materials | ||
EGTX | SEK 5.92 | 0.3% | -3.0% | SEK 2.1b | SEK 11.50 | PS31.3x | E97.3% | n/a | Pharmaceuticals & Biotech | ||
VITR | SEK 208.80 | 4.1% | 24.2% | SEK 28.3b | SEK 272.00 | PS8x | E96.8% | 0.5% | Pharmaceuticals & Biotech | ||
ORT B | SEK 8.36 | -5.9% | -30.3% | SEK 310.0m | SEK 20.00 | PS4.9x | E96.6% | n/a | Healthcare | ||
CIBUS | SEK 169.35 | 4.8% | 42.0% | SEK 10.7b | SEK 184.66 | PS6.6x | E95.4% | 3.7% | Real Estate Management and Development | ||
IMPC | SEK 4.11 | 3.3% | 6.1% | SEK 359.6m | SEK 5.60 | PS2.8x | E95.4% | n/a | Capital Goods | ||
TRIAN B | SEK 20.50 | 10.2% | 24.6% | SEK 4.1b | SEK 22.00 | PS5.3x | E93.9% | 0% | Real Estate Management and Development | ||
MTG B | SEK 102.90 | 5.4% | 32.4% | SEK 12.2b | SEK 140.60 | PS2.1x | E93.2% | 0% | Media | ||
HEXI | SEK 0.19 | 15.4% | -68.9% | SEK 69.1m | n/a | PS8.7x | E93.0% | n/a | Capital Goods | ||
CAST | SEK 118.40 | 5.9% | -10.2% | SEK 58.3b | SEK 125.18 | PS5.6x | E92.8% | 0% | Real Estate Management and Development | ||
LITI | SEK 9.96 | 2.0% | 9.2% | SEK 165.2m | n/a | PE224.1x | E92.7% | n/a | Software |